|Molecular Weight||199.64 (anhydrous basis)|
|Description||Lazabemide, a pyridine derivative, is a reversible and selective monoamine oxidase B inhibitor that has probable effect for Parkinson's disease. IC50: 30 nM. It could also influence the absorption of some monoamines like noradrenalin, serotonin and dopami|
|Synonyms||N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrate, Ro 19-6327 hydrate|
|Solubility||DMSO: ＞ 34 mg/mL|
|Application||Lazabemide is a reversible and selective monoamine oxidase B inhibitor that has probable effect against Parkinson's disease.|
|Shelf Life||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly|
|Boiling Point||397.4ºC at 760mmHg|
Moclobemide is a reversible monoamine oxidase A (MAO-A) inhibitor, displaying antidepressive activity.
Harmane is an endogenous ligand for imidazoline binding sites. It binds to I1-sites in rat kidney (IC50 = 31 nM) and I2-sites (Ki = 49 nM). Harmane also acts as...
Torezolid phosphate is a novel oxazolidinone for gram-positive infections, has an IC50 of 8.7 μM and 5.7 μM for monoamine oxidase (MAO)-A and MAO-B, respectivel...
Tetrindole mesylate is a selective monoamine oxidase A (MAO-A) inhibitor identified as an antidepressant drug candidate.
N 0425 hydrochloride
N 0425 hydrochloride is a potent monoamine oxidase (MAO) inhibitor.
The hydrochloride salt form of Mefexamide which is a psychostimulant.
N 0430 hydrobromide
N 0430 hydrobromide is a monoamine oxidase (MAO) inhibitor and a dopamine agonist.
(-)-N 0425 hydrochloride
(-)-N 0425 hydrochloride is a potent monoamine oxidase (MAO) inhibitor.
Iproniazid phosphate is a non-selective, irreversible inhibitor of monoamine oxidase (MAOI) that has potential to treat hypertension.
Indantadol is a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain.
Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug.
Hemisulphate salt form of Mephentermine which could be a cardioexcitatory agent for acting as a α-adrenoceptor agonist and it has already been used against low ...
Lazabemide, a pyridine derivative, is a reversible and selective monoamine oxidase B inhibitor that has probable effect for Parkinson's disease. IC50: 30 nM. It...
Ro 41-1049 hydrochloride
The hydrochloride salt form of Ro 41-1049 which is a MAO-A inhibitor and probably could be used in the study of Parkinson's disease.
The hydrochloride salt form of Mofegiline which is an irreversible inhibitor of MAO-B and was studied about its potential effect against Parkinson's disease and...
Phenelzine is hydrazine compound as a a non-selective and irreversible monoamine oxidase inhibitor (MAOI).
Pargyline hydrochloride, a benzene derivative, is an irreversible monoamine oxidase (MAO) inhibitor that is used clinically to treat moderate hypertension but i...
Safinamide, a selective MAO-B inhibitor, could be effective against Parkinson’s disease for patients mid-to-late-stage. IC50: 98 nM.
Isocarboxazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) belonging to the hydrazine class. It is primarily used to treat mood and anxie...
N 0432 hydrobromide
N 0432 hydrobromide is a monoamine oxidase (MAO) inhibitor and a dopamine agonist.